España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Liquidia
LQDA
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$12.44
-0.17
-1.35%
At Close: -
$12.35
-0.09
-0.72%
After Hours: 6:13 PM EDT
15 minutes delayed
Get Report
Watch
Liquidia (LQDA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Liquidia (NASDAQ:LQDA) Stock
Liquidia Stock (NASDAQ: LQDA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 10, 2024
HC Wainwright & Co. Reiterates Buy on Liquidi...
Benzinga Newsdesk
Tuesday, June 25, 2024
Forecasting The Future: 5 Analyst Projections For Liquidia
Benzinga Insights
Oppenheimer Initiates Coverage On Liquidia wi...
Benzinga Newsdesk
Monday, June 03, 2024
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Liquidia shares are trading higher after the ...
Benzinga Newsdesk
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Avi Kapoor
7 Analysts Have This To Say About Liquidia
Benzinga Insights
U.S. District Court For District Of Delaware ...
Benzinga Newsdesk
Needham Reiterates Buy on Liquidia, Maintains...
Benzinga Newsdesk
Friday, May 31, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Liquidi...
Benzinga Newsdesk
Liquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Benzinga Insights
Needham Reiterates Buy on Liquidia, Maintains...
Benzinga Newsdesk
Tuesday, May 14, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, May 13, 2024
Liquidia Q1 2024 GAAP EPS $(0.54) Misses $(0....
Benzinga Newsdesk
Thursday, April 25, 2024
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
Avi Kapoor
Wednesday, April 10, 2024
Needham Reiterates Buy on Liquidia, Maintains...
Benzinga Newsdesk
Monday, April 01, 2024
The Analyst Landscape: 5 Takes On Liquidia
Benzinga Insights
Needham Reiterates Buy on Liquidia, Maintains...
Benzinga Newsdesk
Liquidia Says Judge Andrews Has Set Aside Inj...
Benzinga Newsdesk
Wednesday, March 27, 2024
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Monday, March 18, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Thursday, March 14, 2024
HC Wainwright & Co. Maintains Buy on Liquidia...
Benzinga Newsdesk
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, March 13, 2024
Unveiling 6 Analyst Insights On Liquidia
Benzinga Insights
Needham Maintains Buy on Liquidia, Maintains ...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Recap: iShares $ Corp Bond UCITS ETF Q4 Earnings
Benzinga Insights
Liquidia FY GAAP EPS $(1.21) Misses $(1.02) E...
Benzinga Newsdesk
Tuesday, March 12, 2024
Liquidia Earnings Preview
Benzinga Insights
Tuesday, February 27, 2024
United Therapeutics Filed Motion In U.S. Dist...
Benzinga Newsdesk
Wednesday, February 21, 2024
Needham Reiterates Buy on Liquidia, Maintains...
Benzinga Newsdesk
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
Vandana Singh
United Therapeutics Has Commenced Litigation ...
Benzinga Newsdesk
Monday, February 12, 2024
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
Priya Nigam
Thursday, January 25, 2024
Liquidia Unusual Options Activity For January 25
Benzinga Insights
The FDA Informed Liquidia That It Is Adding P...
Benzinga Newsdesk
Tuesday, January 23, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Liquidia Said On Jan 22, United Therapeutics Filed A Stipulation To Dismiss All Claims In The New Hatch-Waxman Litigation Related To '793 Paten
Charles Gross
Monday, January 22, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Friday, January 19, 2024
Liquidia Says That Michael Kaseta, CFO Has Ad...
Benzinga Newsdesk
Wednesday, January 17, 2024
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Monday, January 08, 2024
Liquidia Corporation Files Response To United...
Benzinga Newsdesk
Friday, January 05, 2024
Decoding 5 Analyst Evaluations For Liquidia
Benzinga Insights
Liquidia Provides Update On Clinical Pipeline...
Benzinga Newsdesk
Needham Maintains Buy on Liquidia, Raises Pri...
Benzinga Newsdesk
Thursday, January 04, 2024
Liquidia Corporation Announces $100M In New F...
Benzinga Newsdesk
Friday, December 22, 2023
Liquidia Corp Files For Mixed Shelf Of Up To ...
Benzinga Newsdesk
Thursday, December 21, 2023
Ladenburg Thalmann Maintains Buy on Liquidia,...
Benzinga Newsdesk
B of A Securities Maintains Buy Rating for Liquidia: Here's What You Need To Know
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch